Variant report

Variant	rs73357588
Chromosome Location	chr14:105439000-105439001
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	STAT3	chr14:105438563-105439066	Hela-S3	cervix:	n/a	chr14:105438777-105438789 chr14:105439053-105439065 chr14:105438621-105438629
2	MAX	chr14:105438486-105440257	ECC-1	luminal epithelium:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441
3	FOSL2	chr14:105438352-105439043	MCF-7	breast:	n/a	chr14:105438735-105438747 chr14:105438736-105438746
4	USF1	chr14:105438518-105439176	A549	lung:	n/a	chr14:105439085-105439094 chr14:105439085-105439094
5	POLR2A	chr14:105438492-105440316	HCT-116	colon:	n/a	n/a
6	MYC	chr14:105438876-105439128	Hela-S3	cervix:	n/a	chr14:105439039-105439048 chr14:105439084-105439095 chr14:105439085-105439094 chr14:105439084-105439095
7	FOXA2	chr14:105438417-105439001	A549	lung:	n/a	n/a
8	SIN3AK20	chr14:105438508-105439312	A549	lung:	n/a	n/a
9	TCF12	chr14:105438549-105439024	A549	lung:	n/a	chr14:105438910-105438917
10	POLR2A	chr14:105437942-105440376	Hela-S3	cervix:	n/a	n/a
11	POLR2A	chr14:105438442-105440348	HCT-116	colon:	n/a	n/a
12	MAX	chr14:105438503-105440288	Hela-S3	cervix:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441
13	TBP	chr14:105438236-105440788	Hela-S3	cervix:	n/a	n/a
14	MAX	chr14:105438122-105440113	MCF-7	breast:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105438340-105438350 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441
15	GTF2F1	chr14:105438553-105440779	Hela-S3	cervix:	n/a	n/a
16	BHLHE40	chr14:105438592-105439949	A549	lung:	n/a	chr14:105439085-105439094 chr14:105439085-105439094 chr14:105439627-105439643
17	RAD21	chr14:105438522-105439285	ECC-1	luminal epithelium:	n/a	chr14:105438889-105438903
18	CEBPB	chr14:105438615-105440231	Hela-S3	cervix:	n/a	n/a
19	FOS	chr14:105438551-105440182	Hela-S3	cervix:	n/a	chr14:105438735-105438747 chr14:105438736-105438746 chr14:105439844-105439851 chr14:105439841-105439852 chr14:105439667-105439678 chr14:105439842-105439851
20	POLR2A	chr14:105438578-105440309	A549	lung:	n/a	n/a
21	EGR1	chr14:105438393-105439330	MCF-7	breast:	n/a	n/a
22	FOS	chr14:105438540-105440176	MCF10A-Er-Src	breast:	n/a	chr14:105438735-105438747 chr14:105438736-105438746 chr14:105439844-105439851 chr14:105439841-105439852 chr14:105439667-105439678 chr14:105439842-105439851
23	MXI1	chr14:105438459-105440264	Hela-S3	cervix:	n/a	chr14:105439612-105439627 chr14:105439433-105439442 chr14:105439431-105439440
24	MYC	chr14:105438931-105439170	HUVEC	blood vessel:	n/a	chr14:105439039-105439048 chr14:105439084-105439095 chr14:105439085-105439094 chr14:105439084-105439095
25	FOS	chr14:105438498-105439145	MCF10A-Er-Src	breast:	n/a	chr14:105438735-105438747 chr14:105438736-105438746
26	E2F4	chr14:105438909-105439207	MCF10A-Er-Src	breast:	n/a	n/a
27	HDAC2	chr14:105438415-105439327	MCF-7	breast:	n/a	n/a
28	SMARCC2	chr14:105438591-105440212	Hela-S3	cervix:	n/a	chr14:105439842-105439851
29	JUND	chr14:105438537-105439270	A549	lung:	n/a	chr14:105438735-105438747 chr14:105438736-105438746
30	STAT3	chr14:105438583-105439081	MCF10A-Er-Src	breast:	n/a	chr14:105438777-105438789 chr14:105439053-105439065 chr14:105438621-105438629
31	E2F6	chr14:105438578-105440040	A549	lung:	n/a	n/a
32	FOSL1	chr14:105438337-105440509	HCT-116	colon:	n/a	chr14:105438735-105438747 chr14:105438736-105438746 chr14:105439844-105439851 chr14:105439841-105439852 chr14:105439842-105439851
33	USF1	chr14:105438525-105439244	A549	lung:	n/a	chr14:105439085-105439094 chr14:105439085-105439094
34	POLR2A	chr14:105438495-105440487	U87	brain:	n/a	n/a
35	JUND	chr14:105438334-105440257	MCF-7	breast:	n/a	chr14:105438735-105438747 chr14:105438736-105438746 chr14:105439844-105439851 chr14:105439841-105439852 chr14:105439842-105439851
36	SP1	chr14:105438400-105439185	A549	lung:	n/a	chr14:105439056-105439065
37	EGR1	chr14:105438349-105440449	HCT-116	colon:	n/a	n/a
38	EP300	chr14:105438321-105440432	A549	lung:	n/a	chr14:105439357-105439373 chr14:105439842-105439851 chr14:105438684-105438694
39	ELK1	chr14:105438694-105439097	Hela-S3	cervix:	n/a	n/a
40	POLR2A	chr14:105438307-105440351	Hela-S3	cervix:	n/a	n/a
41	MAX	chr14:105438597-105440046	A549	lung:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441
42	STAT3	chr14:105438538-105439187	MCF10A-Er-Src	breast:	n/a	chr14:105438777-105438789 chr14:105439053-105439065 chr14:105438621-105438629
43	POLR2A	chr14:105438686-105439025	MCF-7	breast:	n/a	n/a
44	MYC	chr14:105438925-105439150	MCF-7	breast:	n/a	chr14:105439039-105439048 chr14:105439084-105439095 chr14:105439085-105439094 chr14:105439084-105439095
45	SIX5	chr14:105438507-105439053	A549	lung:	n/a	n/a
46	SIN3AK20	chr14:105438569-105439282	PANC-1	pancreas:	n/a	n/a
47	JUND	chr14:105438513-105439005	A549	lung:	n/a	chr14:105438735-105438747 chr14:105438736-105438746
48	POLR2A	chr14:105437866-105440264	MCF10A-Er-Src	breast:	n/a	n/a
49	MAX	chr14:105438425-105440827	ECC-1	luminal epithelium:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441
50	MAX	chr14:105437892-105441008	A549	lung:	n/a	chr14:105439616-105439625 chr14:105439430-105439445 chr14:105439432-105439442 chr14:105439432-105439441 chr14:105439039-105439048 chr14:105439612-105439621 chr14:105439084-105439095 chr14:105439430-105439443 chr14:105439085-105439094 chr14:105438340-105438350 chr14:105439084-105439095 chr14:105439948-105439958 chr14:105439431-105439441

No.	Distal block	Cell Line	Cell type
1	chr14:105438438..105439142-chr15:76015812..76016558,2	Hela-S3	cervix:
2	chr14:105437778..105440413-chr14:105535668..105537696,2	MCF-7	breast:
3	chr14:105438202..105442375-chr14:105515554..105517419,4	MCF-7	breast:
4	chr14:105398047..105399858-chr14:105438818..105440320,2	MCF-7	breast:
5	chr14:105437131..105440834-chr14:105498624..105501222,7	MCF-7	breast:
6	chr14:105331052..105332987-chr14:105438030..105440228,2	MCF-7	breast:
7	chr14:105438670..105441192-chr14:105479000..105481836,2	MCF-7	breast:
8	chr14:105438818..105439783-chr14:105511772..105512631,2	K562	blood:
9	chr14:105421158..105428529-chr14:105433571..105439933,9	MCF-7	breast:
10	chr14:105438538..105441421-chr14:105558116..105560287,2	MCF-7	breast:
11	chr14:105438256..105439250-chrX:48900367..48900982,2	Hela-S3	cervix:
12	chr14:105438558..105440399-chr14:105616229..105618880,2	MCF-7	breast:
13	chr14:105336666..105339518-chr14:105438239..105440025,2	MCF-7	breast:
14	chr14:105438710..105440414-chr14:105510653..105512208,2	MCF-7	breast:
15	chr14:105437811..105439685-chr19:4064358..4066215,2	MCF-7	breast:
16	chr14:105437223..105439351-chr14:105956241..105957978,2	MCF-7	breast:
17	chr14:105437250..105440570-chr14:105553722..105556644,3	MCF-7	breast:
18	chr14:105433937..105458439-chr14:105476653..105492775,70	MCF-7	breast:

Variant related genes	Relation type
AHNAK2	TF binding region
ENSG00000178951	Chromatin interaction
ENSG00000185347	Chromatin interaction
ENSG00000166428	Chromatin interaction
ENSG00000182950	Chromatin interaction
ENSG00000170779	Chromatin interaction
ENSG00000099814	Chromatin interaction
ENSG00000185567	Chromatin interaction
ENSG00000068323	Chromatin interaction
ENSG00000257556	Chromatin interaction

Extended variants
information (count: 30 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:8)

rs_ID	r²[population]
rs10133168	0.88[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs10138859	0.86[AMR][1000 genomes];0.93[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2582498	0.85[ASN][1000 genomes]
rs2819446	0.89[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs2819451	0.85[ASN][1000 genomes]
rs28375591	0.84[ASN][1000 genomes]
rs28583515	0.86[ASN][1000 genomes]
rs73357587	0.92[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:22 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1053591	chr14:105024558-105475931	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
2	nsv542224	chr14:105024558-105475931	Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
3	esv1828345	chr14:105100787-105803170	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	165 gene(s)	inside rSNPs	diseases
4	nsv542225	chr14:105133688-105803170	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	165 gene(s)	inside rSNPs	diseases
5	nsv542227	chr14:105157572-105803170	Enhancers Flanking Active TSS Genic enhancers Weak transcription Active TSS Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	147 gene(s)	inside rSNPs	diseases
6	nsv917106	chr14:105339195-105803170	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
7	nsv902419	chr14:105381763-105494262	Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Strong transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
8	nsv1049253	chr14:105384959-105471855	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
9	nsv542228	chr14:105390569-105459912	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
10	nsv456457	chr14:105404384-105555396	Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
11	nsv566141	chr14:105404384-105555396	Weak transcription Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
12	nsv1036224	chr14:105404755-105470333	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
13	nsv902420	chr14:105410183-105494262	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	56 gene(s)	inside rSNPs	diseases
14	nsv902421	chr14:105410183-105574843	Weak transcription Enhancers Genic enhancers Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	73 gene(s)	inside rSNPs	diseases
15	nsv1438	chr14:105412728-105457581	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Weak transcription Enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	32 gene(s)	inside rSNPs	diseases
16	nsv902422	chr14:105420215-105803170	Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS Genic enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
17	nsv1052190	chr14:105423761-105722653	Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	81 gene(s)	inside rSNPs	diseases
18	nsv902423	chr14:105430890-105803170	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
19	nsv1042303	chr14:105435649-105633544	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	73 gene(s)	inside rSNPs	diseases
20	nsv456458	chr14:105435649-105690092	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
21	nsv566150	chr14:105435649-105690092	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
22	nsv902424	chr14:105436222-105803170	Genic enhancers Weak transcription Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	86 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:90 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:105433000-105445400	Flanking Active TSS	Stomach Smooth Muscle	stomach
2	chr14:105433600-105440200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr14:105434400-105443800	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr14:105434600-105439800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr14:105434600-105444000	Weak transcription	Aorta	Aorta
6	chr14:105434800-105439000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr14:105435000-105439800	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr14:105435200-105439000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr14:105435200-105439000	Weak transcription	Right Atrium	heart
10	chr14:105435200-105439800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
11	chr14:105435200-105440400	Weak transcription	Right Ventricle	heart
12	chr14:105435200-105441200	Enhancers	Fetal Stomach	stomach
13	chr14:105435400-105439000	Weak transcription	Left Ventricle	heart
14	chr14:105435800-105439200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
15	chr14:105435800-105439600	Weak transcription	Spleen	Spleen
16	chr14:105435800-105442600	Weak transcription	K562	blood
17	chr14:105436600-105439200	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr14:105436600-105440600	Enhancers	Stomach Mucosa	stomach
19	chr14:105436800-105439600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr14:105436800-105441000	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr14:105436800-105441200	Enhancers	Gastric	stomach
22	chr14:105436800-105441400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr14:105436800-105441600	Enhancers	Fetal Muscle Leg	muscle
24	chr14:105436800-105443400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr14:105436800-105443800	Enhancers	Placenta Amnion	Placenta Amnion
26	chr14:105437000-105439200	Enhancers	NH-A	brain
27	chr14:105437000-105439400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr14:105437200-105439600	Enhancers	Duodenum Smooth Muscle	Duodenum
29	chr14:105437200-105440000	Weak transcription	HUES48 Cell Line	embryonic stem cell
30	chr14:105437400-105439000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
31	chr14:105437400-105439200	Enhancers	NHDF-Ad	bronchial
32	chr14:105437400-105439400	Weak transcription	H1 Cell Line	embryonic stem cell
33	chr14:105437400-105441200	Enhancers	HUVEC	blood vessel
34	chr14:105437400-105441400	Enhancers	Skeletal Muscle Female	skeletal muscle
35	chr14:105437400-105444000	Enhancers	Pancreas	Pancrea
36	chr14:105437600-105439000	Weak transcription	Cortex derived primary cultured neurospheres	brain
37	chr14:105437600-105439200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr14:105438000-105439000	Enhancers	Fetal Intestine Small	intestine
39	chr14:105438000-105439600	Enhancers	Sigmoid Colon	Sigmoid Colon
40	chr14:105438000-105440800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
41	chr14:105438000-105441200	Flanking Active TSS	Hela-S3	cervix
42	chr14:105438000-105441400	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr14:105438000-105446800	Enhancers	Lung	lung
44	chr14:105438200-105439200	Enhancers	Osteobl	bone
45	chr14:105438200-105439400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr14:105438200-105439800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr14:105438200-105440000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr14:105438200-105440000	Flanking Active TSS	NHEK	skin
49	chr14:105438200-105440800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr14:105438200-105440800	Bivalent Enhancer	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links